A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2002
10/17/2002	DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2442996A1 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	CA2442904A1 Benzamidine derivative
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2441538A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	CA2441442A1 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002	WO2001079186A1 2-guanidino-4-arylchinazolines as nhe-3 inhibitors
10/16/2002	EP1248858A1 Antisense modulation of caspase 8 expression
10/16/2002	EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248796A1 Process for the purification of antothrombin-iii
10/16/2002	EP1248791A1 Antisense modulation of caspase 3 expression
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002	EP1248635A1 Antisense modulation of glycogen synthase kinase 3 alpha expression
10/16/2002	EP1248630A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002	EP0941218B1 Antithrombotic organic nitrates
10/16/2002	EP0914147B1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
10/16/2002	EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	CN1374970A Signal sequence for the productino of leu-hirudine via secretion by E coli in a culture medium
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/16/2002	CN1092519C Chinese medicine for argiitis
10/16/2002	CA2406161A1 2-guanidino-4-arylquinazolines as nhe-3 inhibitors
10/15/2002	US6465624 Purification of von-Willebrand factor by cation exchanger chromatography
10/15/2002	US6465496 Dupont form 2 ethanol and isopropanol adducts; suspending torsemide in water, basifying, adding organic solvent, acid precipitating and isolating adduct
10/15/2002	US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465459 Inhibit the enzyme, factor xa
10/15/2002	US6465430 Treating hematological disorders, particularly thrombo-cytopenia resulting from chemotherapy, radiation therapy or bone marrow transfusions; accelerating blood platelet regeneration
10/15/2002	US6464998 Composition for the in vivo production of therapeutic products
10/15/2002	US6464959 Protective colloid stabilizer.
10/15/2002	CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002	CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002	CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002	CA2091766C Enhancement of glutathione levels with glutamine
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002079778A2 In vivo delivery methods and compositions
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002	WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002	WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002	WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002	WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002	WO2002079196A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002	WO2002079181A1 Benzofuran derivatives
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002079145A1 BENZAMIDE INHIBITORS OF FACTOR Xa
10/10/2002	WO2002078738A1 Blood rheology improving agents
10/10/2002	WO2002078705A1 Hsp inductor
10/10/2002	WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002	WO2002078612A2 Thrombopoietin (tpo) synthebody for stimulation of platelet production
10/10/2002	WO2002078602A2 Transdermal delivery of pergolide
10/10/2002	WO2002078564A2 Method for creating a separation of posterior cortical vitreous from the retina of the eye
10/10/2002	WO2002062212A3 A personal condition management system
10/10/2002	WO2002058749A3 Carrier with solid fibrinogen and solid thrombin
10/10/2002	WO2002051460A3 Bioactive materials for aneurysm repair
10/10/2002	WO2002046373A8 Method of collecting placental stem cells
10/10/2002	WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002	WO2002029045A3 Method for the production of vitamin k-dependent proteins
10/10/2002	WO2002029025A3 Factor vii glycoforms
10/10/2002	WO2002004612A3 Drug metabolizing enzymes
10/10/2002	WO2001098353A3 Secreted proteins
10/10/2002	WO2001093845A3 Carboxyalkylether-acat inhibitor combinations
10/10/2002	WO2001077174A3 Human transporters and ion channels
10/10/2002	US20020147346 New crystal modification of torasemide
10/10/2002	US20020147228 Adjust concentration of albumin in blood
10/10/2002	US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002	US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002	US20020147180 Stable amorphous amifostine compositions and methods for the preparation of same
10/10/2002	US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002	US20020146786 Bacillus natto culture extract
10/10/2002	US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002	US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002	US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002	US20020146408 Human haemopoietic maturation factor
10/10/2002	US20020146386 In vivo use of water absorbent polymers
10/10/2002	DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002	DE10116978A1 Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase Kappa-opiate agonist for the treatment of diseases of the bladder
10/10/2002	DE10116589A1 Use of creatine for reducing oxidative stress e.g. for treating aging, neurodegeneration and cancers
10/10/2002	CA2443128A1 Transdermal delivery of pergolide
10/10/2002	CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002	CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002	CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002	CA2442265A1 Benzofuran derivatives
10/10/2002	CA2442263A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002	CA2442064A1 G-protein coupled receptors
10/10/2002	CA2442062A1 Secreted proteins
10/10/2002	CA2441654A1 Cytoskeleton-associated proteins
10/10/2002	CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 671